France
DÔMES PHARMA is an independent, family-owned pharmaceutical company that has been making a positive impact since 1947. With a firm foothold in France, England, Germany, Spain, and the USA, the company employs a workforce of 400 and boasts a consolidated turnover of 90 million euros.
For over 70 years, the company has been dedicated to developing, manufacturing, and marketing solutions for the health and well-being of pets. Their expertise spans healthcare and pharmaceuticals, covering all facets of the medicine value chain across various distribution channels.
Despite the lack of publicly available details on the last investment and its associated investors, DÔMES PHARMA's long-standing presence in the industry and its commitment to making a positive impact make it an intriguing prospect for potential investors seeking to venture into the pharmaceutical space. With a strong foundation and a focus on enhancing the well-being of pets, the company presents an opportunity for investment that aligns with both financial and social objectives.
